Viral Hepatitis Flashcards

1
Q

What family and genus does HAV belong to?

A

Picornaviridae and Enterovirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the structure of HAV?

A

Nonenveloped icosahedral capsid ss RNA (+) (less than 7 kb)

Single serotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What family and genus does HEV?

A

Family Caliciviridae and Hepevirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the structure of HEV?

A

Nonenveloped icosahedral capsid 7.5 kb ss RNA (+)

Single serotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the reservoirs of HAV? HEV?

A

HAV: Humans

HEV: Possible swine, mostly prevalent in developing countries, only causes FLF in pregnant women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the pathogenesis of HAV

A

It is contracted via a fecal-oral route, with replication occuring in the GI tract during the ~2 week incubation period. Contraction is most common early disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does HAV present?

A

Often asymptomatic with symptoms including anorexia, malaise, fever, HA, and possibly jaundice over a 4-5 week period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What groups are at risk fo HAV?

A
  • Household or sexual contacts
  • Travelers to endemic areas
  • Inhabitants of American Indian reservations
  • During outbreaks: Diners, Day care center workers, Gay men, Injecting drug users
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is HAV diagnosed?

A
  • Presumptive diagnosis on appearance and history
  • Detection of anti-HAV IgM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What vaccine options are available for HAV?

A
  • Passive immunization with gamma globulin
  • Inactivated vaccine (Havrix) in those 2 years of age or older
  • Combination vaccine for HAV and HBV (Twinrix): Havrix plus recombinant HBV vaccine. Only for those 18 years of age or older
  • Vaccine or gamma globulin is recommended for travelers to endemic areas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hepatitis Virus Nomenclature

A

HAV: ET-hepatitis

HBV: PT-hepatitis

HCV: “nonA, nonB” PT-hepatitis

HDV: dependent on HBV for infection

HEV: “nonA, nonB” ET-hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the structure of HBV?

A

Hepadnavirus

Enveloped virus termed Dane particle

Partially ds DNA genome, 3200 bp

Structure: Circular coat protein (HBsAg) surrounded circular core (HBcAg) containing DNA genome and polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the 5 major proteins of HBV?

A

DNA polymerase (reverse transcriptase)

HBsAg: surface antigen, attachment protein (Mostly found in 20 nm particles and filaments)

  • HBcAg: core antigen, capsid protein
  • HBeAg: derivative of HBcAg, important serolgic marker
  • X antigen: influences gene expression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does HBV replicate?

A

Fusion endocytosis followed by uncoating of the core, completion of ds DNA genome and then entry into the nucleus for transcription. Translation occurs in the cytosol via reverse transcriptase to produce a partial ds DNA genome, which is then mostly maintained extrachromosomally in chronic infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where is HBV most common?

A
  • Endemic to China and sub-Saharan Africa
  • Late infection in US and Europe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is HBV transmitted?

A

Virus is present in blood, semen, and vaginal secretions

Transmission is by parenteral route

-Injection drug use

-Sexual intercourse

-Perinatal at delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What does a positive HBsAg suggest?

A

carrier or acute infection of HBV

18
Q

What does a positive Anti-Hb Ab suggest?

A

a pt has had HBV or received vaccine

19
Q

What does a positive HBeAg suggest?

A

these pts are at an increased risk of transmission (positive Anti-HBe is used to ID HBsAg carrier with low risk of transmission)

20
Q

What does a positive Anti-HBc suggest?

A

ID of persons with past infection

21
Q

What does a positive IgM Anti-HBc suggest?

A

ID of acute or recent infection

22
Q

Describe HDV

A
  • Encodes delta antigen, its core protein
  • Enveloped, circular ss RNA genome of 1.7 kb

-HDV particles must incorporate HBsAg to infect hepatocytes

23
Q

What is the family of Hep C?

A

Flavivirdae

24
Q

Describe the structure of Hep C

A
  • Hepacivirus
  • Enveloped icosahedral capsid
  • 9.4 kb ss RNA (+) genome
25
Q

What are the genotypes of HCV?

A
  • 6 major genotypes, further divided into subtypes
  • 1a, 1b, 2a, 2b are worldwide
  • 1a and 1b are most common in US
  • Patients also contain quasi-species
26
Q

Where is HCV most common?

A

Highest incidence in Asia, Middle East and Nort Africa with incidence dropping in the US

27
Q

What are the risk factors of contracting HCV?

A

Born between 1945-1965 (80% of chronic cases)

Illicit (injection) drug use

Perinatal infection at birth

Prison

28
Q

T or F. Acute infections of HCV are milder than HBV

A

T.

29
Q

How does the immune system affect hepatitis?

A

Hepatitis viruses are not cytolytic

Immune destruction (cytotoxic T cells) of infected hepatocytes leads to liver disease

30
Q

What most commonly causes chronic hepatitis?

A
  • 40% of cases are due to HCV
  • 20% due to HBV
  • 5% contain HDV
  • Remainder of unknown origin
31
Q

The development of chronic HBV depends heabvily on what?

A

the age of initial infection

< 1 yo: 90% chronicity rate

1-5 yo: 30% rate

> 5 yo: 2% rate

32
Q

How deadly is chronic HBV?

A

25% mortality, most commonly in the 60s

33
Q

What are the stages of chronic HBV?

A
  • Immune tolerance phase
  • Immune clearance phase
  • Residual phase
34
Q

What are the major outcomes of acute Hep B?

A

90% resolve, 1% lead to fulminant hepatitis, and 9% progressive to chronicity (HBsAg+ for 6+ mos)

35
Q

What are the major outcomes of chronic Hep B?

A

50% resolve

  • asymptomatic carrier state
  • chronic persistant hepaitis or chronic acute hepatitis leading to cirrhosis, HCC, and/or extrahepatic disease
36
Q

What are the major outcomes of untreated acute HCV?

A

15% resolve

85% on untreated will lead to chronic infection leading to liver failure, cirrhosis, or HCC

37
Q

Notes

A

Immunize HBV and HCV chronic patients against HAV

Discourage alcohol use

HBV and HCV liver disease is the leading reason for liver transplants

Despite HBV vaccine, HBV-related cancers and deaths have doubled in the past decade

38
Q

Diagnosis of Hep at presentation

A

1) Acute forms of ET- and PT-hepatitis can be similar
2) Determine Source of infection and ELISA
- HBV: HBsAg, anti-HBc IgM; HBeAg, HBe antibody, HBV DNA
- HCV: anti-HCV antibodies, HCV RNA
3) Determine HCV genotype

39
Q

HBV control

A

Screen blood supplies for HBsAg, HBc antibodies, HBV DNA

Vaccines

  • (Plasma-derived HBsAg)
  • Yeast expressed HBsAg
  • Twinrix
  • Childhood immunization recommended

HBIg for exposed individuals

  • Newborns
  • Can be used prophylactically for travelers
40
Q

What is the goal of HBV antivirals?

A

Goal is to reduce the risk of progressive chronic disease, transmission, and complications (cirrhosis, HCC)

41
Q

What are some indications to initiate HBV antiviral therapy?

A

>2000 units/mL HBV DNA

>2x upper normal limit of serum ALT

42
Q

HCV Control

A

Screen blood supplies for antibodies to core antigen, HCV RNA

  • No vaccine in US yet, no passive immunization
  • “HCV is relatively easily treated and can be eliminated in almost all patients.”
  • Thus, goal of therapy is to eliminate HCV RNA
  • Treatment varies by genotype